BIOA BioAge Labs, Inc. - Common Stock
$10.65
Price · Aug 19, 2026
Fundamentals as of Aug 5, 2026
52W Range
$4–$26
29% of range
Analyst Rating
STRONG BUY
15 analysts
Price Target
$36
+235% upside
P/E (TTM)
-5.6
ROE
-28.4%
Net Profit Margin
-896.1%
BIOA Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$10.65
Market Cap
$473M
P/E (TTM)
-5.6
EPS (TTM)
$-2.24
Revenue (TTM)
$9M
Div Yield
—
ROE
-28.4%
Debt/Equity
0.0
52W Range
$4 – $26
BIOA Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
10-Year Performance Revenue, net income, margins and EPS trends
Revenue & Net Income
$9M
2024-12-31
→
2025-12-31
EPS
$-2.24
2023-12-31
→
2025-12-31
Free Cash Flow
$-82M
2024-12-31
→
2025-12-31
Margins
-896.1%
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
BIOA
Peer Median
P/E (TTM)
-5.6
11.7
P/S (TTM)
52.6
5.4
P/B
1.7
3.7
EV / EBITDA
-2.1
—
Price / FCF
-5.7
—
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
BIOA
Peer Median
Operating Margin
-1031.5%
—
Net Profit Margin
-896.1%
-45.6%
ROA
-24.7%
-25.4%
ROE
-28.4%
-27.1%
ROIC
-33.8%
—
Financial Health Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
BIOA
Peer Median
Debt / Equity
0.0
—
Current Ratio
14.2
4.6
Quick Ratio
14.0
—
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
BIOA
Peer Median
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
BIOA
Peer Median
BIOA Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
BUY
15 analysts
- Strong Buy 6 40.0%
- Buy 6 40.0%
- Hold 3 20.0%
- Sell 0 0.0%
- Strong Sell 0 0.0%
12-Month Price Target
8 analysts · 2026-08-17
Median
$30.00
Mean
$35.62
← Below all targets
$10.65
Low
$20.00
High
$73.00
Median target
$30.00
+181.7%
Mean target
$35.62
+234.5%
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
0.07%
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| June 30, 2026 | $-0.58 | $-0.62 | 0.04% |
| March 31, 2026 | $-0.52 | $-0.65 | 0.13% |
| Dec. 31, 2025 | $-0.72 | $-0.75 | 0.03% |
| Sept. 30, 2025 | $-0.56 | $-0.60 | 0.04% |
| June 30, 2025 | $-0.60 | $-0.49 | -0.11% |
| March 31, 2025 | $-0.36 | $-0.54 | 0.18% |
| Dec. 31, 2024 | $-1.97 | $-2.12 | 0.15% |
Peer comparison (GICS sub-industry) Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| BIOA | $495M | -5.9 | — | -896.1% | -28.4% | — |
| CTNM | — | -5.3 | — | — | -27.7% | — |
| EOLS | $432M | -8.3 | 11.6% | -17.4% | 247.3% | 66.3% |
| AQST | $788M | -8.3 | -22.6% | -188.1% | 157.7% | — |
| RLMD | $354M | -3.3 | 93.7% | — | -112.0% | — |
| AVIR | $279M | -1.8 | — | — | -49.5% | — |
| LLY | — | 46.8 | 44.7% | 31.7% | 101.2% | — |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement 14
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| Revenue | $9M | $0 | |
| R&D Expense | $74M | $59M | |
| SG&A Expense | $28M | $19M | |
| Operating Expenses | $102M | $78M | |
| Operating Income | $-93M | $-78M | |
| Other Non-op | $12M | $7M | |
| Pretax Income | $-81M | $-71M | |
| Income Tax | $0 | $0 | |
| Net Income | $-81M | $-71M | |
| EPS (Basic) | $-2.24 | $-6.63 | |
| EPS (Diluted) | $-2.24 | $-6.63 | |
| Shares (Basic) | 35,932,914 | 10,726,521 | |
| Shares (Diluted) | 35,932,914 | 10,726,521 | |
| EBITDA | $-93M | $-78M |
Balance Sheet 23
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| Cash & Equivalents | $189M | $354M | |
| Short-term Investments | $92M | $0 | |
| Receivables | $769.0K | $0 | |
| Prepaid Expense | $5M | $3M | |
| Current Assets | $287M | $357M | |
| PP&E (Net) | $963.0K | $591.0K | |
| PP&E (Gross) | $1M | $962.0K | |
| Accum. Depreciation | $482.0K | $371.0K | |
| Other Non-current Assets | $216.0K | $240.0K | |
| Total Assets | $295M | $358M | |
| Accounts Payable | $3M | $2M | |
| Current Liabilities | $20M | $28M | |
| Capital Leases | $2M | $0 | |
| Total Liabilities | $23M | $35M | |
| Long-term Debt | $3M | $9M | |
| Total Debt | $3M | $9M | |
| Common Stock | $0 | $0 | |
| Paid-in Capital | $605M | $576M | |
| Retained Earnings | $-333M | $-253M | |
| AOCI | $278.0K | $245.0K | |
| Stockholders' Equity | $272M | $323M | |
| Liabilities + Equity | $295M | $358M | |
| Shares Outstanding | 37,386,908 | 35,850,037 |
Cash Flow 10
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| Stock-based Comp | $12M | $7M | |
| Operating Cash Flow | $-82M | $-52M | |
| CapEx | $719.0K | $366.0K | |
| Investing Cash Flow | $-95M | $-366.0K | |
| Stock Issued | $17M | $0 | |
| Net Stock Activity | $17M | · | |
| Financing Cash Flow | $11M | $381M | |
| Net Change in Cash | $-165M | $329M | |
| Taxes Paid | $0 | $0 | |
| Free Cash Flow | $-82M | $-52M |
Profitability 7
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| Operating Margin | -1031.5% | · | |
| Net Margin | -896.1% | · | |
| Pretax Margin | -896.1% | · | |
| EBITDA Margin | -1031.5% | · | |
| ROA | -24.7% | -37.0% | |
| ROE | -28.4% | -22.3% | |
| ROIC | -33.8% | -23.6% |
Liquidity & Solvency 4
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| Current Ratio | 14.2 | 12.9 | |
| Quick Ratio | 14.0 | 12.8 | |
| Debt / Equity | 0.0 | 0.0 | |
| LT Debt / Equity | 0.0 | 0.0 |
Efficiency 2
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| Asset Turnover | 0.0 | · | |
| Receivables Turnover | 23.4 | · |
Valuation (TTM) 14
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| Revenue TTM | $9M | $0 | |
| Net Income TTM | $-81M | $-71M | |
| Market Cap | $495M | $208M | |
| Enterprise Value | $216M | $-138M | |
| P/E | -5.9 | -0.9 | |
| P/S | 55.0 | · | |
| P/B | 1.8 | 0.6 | |
| P / Tangible Book | 1.8 | 0.6 | |
| P / Cash Flow | -6.1 | -4.0 | |
| P / FCF | -6.0 | -4.0 | |
| EV / EBITDA | -2.3 | 1.8 | |
| EV / FCF | -2.6 | 2.7 | |
| EV / Revenue | 24.0 | · | |
| Earnings Yield | -16.9% | -114.5% |
Income Statement 12
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2M | $3M | $3M | $2M | $2M | $1M | $0 | $0 | $0 | |
| R&D Expense | $24M | $20M | $24M | $19M | $20M | $11M | $19M | $20M | $10M | |
| SG&A Expense | $7M | $8M | $7M | $7M | $7M | $7M | $6M | $5M | $5M | |
| Operating Expenses | $32M | $28M | $32M | $25M | $27M | $18M | $25M | $25M | $15M | |
| Operating Income | $-29M | $-25M | $-28M | $-23M | $-25M | $-16M | $-25M | $-25M | $-15M | |
| Other Non-op | $3M | $3M | $2M | $3M | $3M | $4M | $4M | $1M | $2M | |
| Net Income | $-26M | $-22M | $-26M | $-20M | $-22M | $-13M | $-21M | $-23M | $-14M | |
| EPS (Basic) | $-0.58 | $-0.52 | $-0.72 | $-0.56 | $-0.60 | $-0.36 | $15.77 | $-6.70 | $-7.94 | |
| EPS (Diluted) | $-0.58 | $-0.52 | $-0.72 | $-0.56 | $-0.60 | $-0.36 | $15.77 | $-6.70 | $-7.94 | |
| Shares (Basic) | 44,838,893 | 42,480,488 | -71,617,197 | 35,850,037 | 35,850,037 | 35,850,037 | 3,847,464 | 3,494,580 | 1,711,005 | |
| Shares (Diluted) | 44,838,893 | 42,480,488 | -71,617,197 | 35,850,037 | 35,850,037 | 35,850,037 | 3,847,464 | 3,494,580 | 1,711,005 | |
| EBITDA | $-29M | $-25M | · | $-23M | $-25M | $-16M | · | $-25M | · |
Balance Sheet 23
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $74M | $242M | $189M | $216M | $220M | $257M | $354M | $334M | · | |
| Short-term Investments | $245M | $141M | $92M | $70M | $77M | $63M | $0 | · | · | |
| Receivables | $625.0K | $709.0K | $769.0K | $515.0K | $603.0K | $361.0K | $0 | · | · | |
| Prepaid Expense | $11M | $8M | $5M | $5M | $4M | $4M | $3M | $2M | · | |
| Current Assets | $330M | $392M | $287M | $291M | $302M | $325M | $357M | $336M | · | |
| PP&E (Net) | $1M | $1M | $963.0K | $973.0K | $974.0K | $929.0K | $591.0K | $543.0K | · | |
| PP&E (Gross) | $2M | $2M | $1M | $1M | $1M | $1M | $962.0K | $1M | · | |
| Accum. Depreciation | $613.0K | $543.0K | $482.0K | $413.0K | $462.0K | $408.0K | $371.0K | $540.0K | · | |
| Other Non-current Assets | $208.0K | $215.0K | $216.0K | $227.0K | $237.0K | $239.0K | $240.0K | · | · | |
| Total Assets | $397M | $398M | $295M | $305M | $322M | $344M | $358M | $337M | · | |
| Accounts Payable | $6M | $3M | $3M | $5M | $1M | $4M | $2M | $2M | · | |
| Current Liabilities | $19M | $16M | $20M | $24M | $23M | $24M | $28M | $19M | · | |
| Capital Leases | $2M | $2M | $2M | $2M | $3M | $3M | $0 | · | · | |
| Total Liabilities | $22M | $19M | $23M | $28M | $27M | $31M | $35M | $24M | · | |
| Long-term Debt | · | · | $3M | $4M | $6M | $7M | $9M | $10M | · | |
| Total Debt | $0 | $1M | · | $4M | $6M | $7M | · | $10M | · | |
| Common Stock | $0 | $0 | $0 | $0 | $0 | · | $0 | · | · | |
| Paid-in Capital | $757M | $735M | $605M | $585M | $582M | $579M | $576M | $545M | · | |
| Retained Earnings | $-382M | $-356M | $-333M | $-307M | $-287M | $-266M | $-253M | $-232M | · | |
| AOCI | $-478.0K | $73.0K | $278.0K | $275.0K | $212.0K | $264.0K | $245.0K | $109.0K | · | |
| Stockholders' Equity | $375M | $379M | $272M | $277M | $295M | $313M | $323M | $314M | · | |
| Liabilities + Equity | $397M | $398M | $295M | $305M | $322M | $344M | $358M | $337M | · | |
| Shares Outstanding | 45,776,902 | 44,386,785 | 37,386,908 | 35,850,037 | 35,850,037 | 35,850,037 | 35,850,037 | 34,196,821 | · |
Cash Flow 7
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $4M | $4M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | |
| Operating Cash Flow | $-19M | $-24M | $-28M | $-16M | $-20M | $-17M | $-5M | $-15M | $-16M | |
| CapEx | $328.0K | $26.0K | $112.0K | $22.0K | $159.0K | $426.0K | $26.0K | $305.0K | $35.0K | |
| Investing Cash Flow | $-165M | $-47M | $-14M | $13M | $-16M | $-78M | $-26.0K | $-305.0K | $-35.0K | |
| Financing Cash Flow | $16M | $124M | $16M | $-2M | $-2M | $-2M | $25M | $191M | $-2M | |
| Net Change in Cash | $-168M | $53M | $-27M | $-5M | $-37M | $-97M | $20M | $175M | $-18M | |
| Free Cash Flow | · | $-24M | · | · | · | $-18M | · | · | · |
Profitability 5
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1196.8% | -915.4% | · | -1126.6% | -1027.0% | -1133.4% | · | · | · | |
| Net Margin | -1064.8% | -802.8% | · | -982.0% | -894.0% | -891.0% | · | · | · | |
| EBITDA Margin | -1196.8% | -915.4% | · | -1126.6% | -1027.0% | -1133.4% | · | · | · | |
| ROA | -7.3% | -6.0% | · | -6.3% | -13.4% | -7.5% | · | -13.9% | · | |
| ROE | -7.8% | -6.4% | · | -6.8% | -14.6% | -8.3% | · | -14.9% | · |
Liquidity & Solvency 4
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 17.2 | 24.8 | · | 11.9 | 13.2 | 13.7 | · | 17.6 | · | |
| Quick Ratio | 16.6 | 24.3 | · | 11.7 | 13.0 | 13.5 | · | 17.5 | · | |
| Debt / Equity | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | · | |
| LT Debt / Equity | · | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | · |
Efficiency 2
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | · | · | |
| Receivables Turnover | 4.0 | 5.2 | · | 8.0 | 8.0 | 8.0 | · | · | · |
Valuation (TTM) 14
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $10M | $9M | · | $6M | $4M | · | · | · | · | |
| Net Income TTM | $-90M | $-77M | · | $-78M | $-71M | $-63M | · | $-65M | · | |
| Market Cap | $1.12B | $776M | · | $211M | $148M | $135M | · | $711M | · | |
| Enterprise Value | $803M | $394M | · | $-71M | $-144M | $-179M | · | $387M | · | |
| P/E | -10.8 | -8.6 | · | -0.7 | -0.3 | -0.2 | · | -0.7 | · | |
| P/S | 115.8 | 89.3 | · | 35.6 | 38.3 | · | · | · | · | |
| P/B | 3.0 | 2.0 | · | 0.8 | 0.5 | 0.4 | · | 2.3 | · | |
| P / Tangible Book | 3.0 | 2.0 | · | 0.8 | 0.5 | 0.4 | · | 2.3 | · | |
| P / Cash Flow | · | -32.3 | · | · | · | -7.8 | · | · | · | |
| P / FCF | · | -32.3 | · | · | · | -7.6 | · | · | · | |
| EV / EBITDA | -27.4 | -15.5 | · | 3.1 | 5.8 | 10.9 | · | -15.6 | · | |
| EV / FCF | · | -16.4 | · | · | · | 10.0 | · | · | · | |
| EV / Revenue | 82.9 | 45.4 | · | -12.0 | -37.2 | · | · | · | · | |
| Earnings Yield | -9.2% | -11.7% | · | -139.8% | -377.7% | -605.3% | · | -149.7% | · |
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
Income Statement
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Revenue | $9M | $0 | — |
| Operating Margin % | -1031.5% | — | — |
| Net Income | $-81M | $-71M | $-64M |
| Diluted EPS | $-2.24 | $-6.63 | $-38.17 |
Balance Sheet
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Debt / Equity | 0.0 | 0.0 | — |
| Current Ratio | 14.2 | 12.9 | — |
| Quick Ratio | 14.0 | 12.8 | — |
Cash Flow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Free Cash Flow | $-82M | $-52M | — |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Institutional owners (13F) 169 filers · $825.4M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 42 (-7 vs prior Q) | 19 (+3 vs prior Q) | 51 (+7 vs prior Q) | 43 (+18 vs prior Q) | +3.0M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| a16z Capital Management, L.L.C. | $79,244,997 | 3,233,170 | 9.60% | Shares |
| Cormorant Asset Management, LP | $58,593,729 | 2,390,605 | 7.10% | Shares |
| Sofinnova Investments, Inc. | $56,220,744 | 2,293,788 | 6.81% | Shares |
| Octagon Capital Advisors LP | $42,843,480 | 1,748,000 | 5.19% | Shares |
| RA CAPITAL MANAGEMENT, L.P. | $40,972,092 | 1,671,648 | 4.96% | Shares |
| MPM BIOIMPACT LLC | $40,874,371 | 1,667,661 | 4.95% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $37,848,685 | 1,544,214 | 4.59% | Shares |
| JANUS HENDERSON GROUP PLC | $36,597,368 | 2,094,270 | 4.43% | Shares |
| Polar Capital Holdings Plc | $26,283,151 | 1,072,344 | 3.18% | Shares |
| BRAIDWELL LP | $25,321,992 | 1,033,129 | 3.07% | Shares |
| STATE STREET CORP | $25,036,083 | 1,021,464 | 3.03% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $21,542,373 | 878,729 | 2.61% | Shares |
| Sands Capital Alternatives, LLC | $19,273,512 | 786,353 | 2.34% | Shares |
| ORBIMED ADVISORS LLC | $18,435,270 | 752,153 | 2.23% | Shares |
| Balyasny Asset Management L.P. | $17,227,050 | 702,858 | 2.09% | Shares |
| D. E. Shaw & Co., Inc. | $16,771,139 | 684,257 | 2.03% | Shares |
| VANGUARD GROUP INC | $16,418,324 | 1,240,992 | 1.99% | Shares |
| Pivotal bioVenture Partners Investment Advisor LLC | $16,014,197 | 653,374 | 1.94% | Shares |
| COSMIC MANAGEMENT, LLC | $12,299,927 | 501,833 | 1.49% | Shares |
| STEMPOINT CAPITAL LP | $11,376,831 | 464,171 | 1.38% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $10,053,144 | 410,165 | 1.22% | Shares |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $9,242,353 | 377,085 | 1.12% | Shares |
| DIMENSIONAL FUND ADVISORS LP | $8,778,158 | 358,146 | 1.06% | Shares |
| Walleye Capital LLC | $8,686,221 | 354,395 | 1.05% | Shares |
| Integral Health Asset Management, LLC | $7,353,000 | 300,000 | 0.89% | Shares |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $7,353,000 | 300,000 | 0.89% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $7,267,215 | 296,500 | 0.88% | Call option |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $6,700,323 | 273,371 | 0.81% | Shares |
| Comprehensive Financial Management LLC | $6,662,847 | 271,842 | 0.81% | Shares |
| BANK OF AMERICA CORP /DE/ | $6,320,026 | 257,855 | 0.77% | Shares |
| Squadron Capital Management LLC | $6,127,500 | 250,000 | 0.74% | Call option |
| MILLENNIUM MANAGEMENT LLC | $5,456,441 | 222,621 | 0.66% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $5,382,396 | 219,600 | 0.65% | Shares |
| SPHERA FUNDS MANAGEMENT LTD. | $5,237,076 | 213,671 | 0.63% | Shares |
| DIADEMA PARTNERS LP | $4,904,451 | 200,100 | 0.59% | Call option |
| Ikarian Capital, LLC | $4,901,999 | 200,000 | 0.59% | Shares |
| GOLDMAN SACHS GROUP INC | $4,599,081 | 187,641 | 0.56% | Shares |
| FMR LLC | $4,499,129 | 183,563 | 0.55% | Shares |
| Yiheng Capital Management, L.P. | $4,179,739 | 170,532 | 0.51% | Shares |
| MORGAN STANLEY | $4,071,430 | 166,113 | 0.49% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $4,061,307 | 165,700 | 0.49% | Shares |
| Squadron Capital Management LLC | $3,799,050 | 155,000 | 0.46% | Shares |
| DIADEMA PARTNERS LP | $3,586,646 | 146,334 | 0.43% | Shares |
| Ensign Peak Advisors, Inc | $3,473,018 | 141,698 | 0.42% | Shares |
| UBS Group AG | $2,522,716 | 102,926 | 0.31% | Shares |
| NEXTBio Capital Management LP | $2,468,941 | 100,732 | 0.30% | Shares |
| Burkehill Global Management, LP | $2,451,000 | 100,000 | 0.30% | Shares |
| Alessandra Capital Management, LLC | $2,288,459 | 93,368 | 0.28% | Shares |
| CITADEL ADVISORS LLC | $1,920,726 | 78,365 | 0.23% | Shares |
| Caption Management, LLC | $1,838,250 | 75,000 | 0.22% | Call option |
| BNP PARIBAS FINANCIAL MARKETS | $1,752,146 | 71,487 | 0.21% | Shares |
| Birchview Capital, LP | $1,691,190 | 69,000 | 0.20% | Shares |
| Squarepoint Ops LLC | $1,677,366 | 68,436 | 0.20% | Shares |
| TWO SIGMA INVESTMENTS, LP | $1,504,767 | 61,394 | 0.18% | Shares |
| BOOTHBAY FUND MANAGEMENT, LLC | $1,504,424 | 61,380 | 0.18% | Shares |
| AMERIPRISE FINANCIAL INC | $1,450,943 | 59,198 | 0.18% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1,431,384 | 58,400 | 0.17% | Put option |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1,422,193 | 58,025 | 0.17% | Shares |
| AMERICAN CENTURY COMPANIES INC | $1,342,658 | 54,780 | 0.16% | Shares |
| Quantinno Capital Management LP | $1,254,618 | 51,188 | 0.15% | Shares |
| SEVEN GRAND MANAGERS, LLC | $1,225,500 | 50,000 | 0.15% | Shares |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $1,214,348 | 49,545 | 0.15% | Shares |
| Moody Aldrich Partners LLC | $1,164,004 | 47,491 | 0.14% | Shares |
| SIMPLEX TRADING, LLC | $1,158,832 | 47,280 | 0.14% | Shares |
| Bank of New York Mellon Corp | $1,118,416 | 45,631 | 0.14% | Shares |
| RHUMBLINE ADVISERS | $1,076,080 | 43,904 | 0.13% | Shares |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $1,029,420 | 42,000 | 0.12% | Shares |
| Corient Private Wealth LP | $986,724 | 40,778 | 0.12% | Shares |
| BlackRock, Inc. | $985,400 | 40,204 | 0.12% | Shares |
| Persistent Asset Partners Ltd | $913,071 | 37,253 | 0.11% | Shares |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | $866,183 | 35,340 | 0.10% | Shares |
| DEUTSCHE BANK AG\ | $840,644 | 34,298 | 0.10% | Shares |
| ALLIANCEBERNSTEIN L.P. | $799,293 | 45,700 | 0.10% | Shares |
| CITADEL ADVISORS LLC | $794,124 | 32,400 | 0.10% | Put option |
| Militia Capital Management LLC | $791,330 | 32,286 | 0.10% | Shares |
| Vanguard Global Advisers, LLC | $781,011 | 31,865 | 0.09% | Shares |
| MARSHALL WACE, LLP | $778,021 | 31,743 | 0.09% | Shares |
| WELLINGTON MANAGEMENT GROUP LLP | $735,349 | 30,002 | 0.09% | Shares |
| CITIGROUP INC | $697,138 | 28,443 | 0.08% | Shares |
| STATE OF WISCONSIN INVESTMENT BOARD | $689,883 | 28,147 | 0.08% | Shares |
| CITADEL ADVISORS LLC | $681,378 | 27,800 | 0.08% | Call option |
| PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | $681,084 | 27,788 | 0.08% | Shares |
| XTX Topco Ltd | $656,696 | 26,793 | 0.08% | Shares |
| WEXFORD CAPITAL LP | $631,500 | 25,765 | 0.08% | Shares |
| MILLENNIUM MANAGEMENT LLC | $612,750 | 25,000 | 0.07% | Call option |
| JANE STREET GROUP, LLC | $590,421 | 24,089 | 0.07% | Shares |
| Caption Management, LLC | $569,612 | 23,240 | 0.07% | Shares |
| STRS OHIO | $539,220 | 22,000 | 0.07% | Shares |
| BARCLAYS PLC | $538,779 | 21,982 | 0.07% | Shares |
| Militia Capital Partners, LP | $533,169 | 40,300 | 0.06% | Shares |
| MetLife Investment Management, LLC | $511,989 | 20,889 | 0.06% | Shares |
| Stonepine Capital Management, LLC | $490,200 | 20,000 | 0.06% | Shares |
| BANK OF NOVA SCOTIA | $490,200 | 20,000 | 0.06% | Shares |
| Man Group plc | $444,783 | 18,147 | 0.05% | Shares |
| Virtus Investment Advisers, LLC | $444,538 | 18,137 | 0.05% | Shares |
| Verdad Advisers, LP | $426,327 | 17,394 | 0.05% | Shares |
| JANE STREET GROUP, LLC | $409,317 | 16,700 | 0.05% | Put option |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $396,743 | 16,187 | 0.05% | Shares |
| GREAT LAKES ADVISORS, LLC | $390,493 | 15,932 | 0.05% | Shares |
| Y-Intercept (Hong Kong) Ltd | $373,532 | 15,240 | 0.05% | Shares |
Company insiders 9 insiders · 3 officers · 6 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| GOLDSTEIN DOV A MD | Chief Financial Officer | April 23, 2026 M | 36,575 | 0 | 4 | $-531,844 |
| Shane Barton | Principal Accounting Officer | June 30, 2026 M | 0 | 0 | 2 | $-1,576,885 |
| Paul D Rubin | Chief Medical Officer | April 1, 2026 M | 0 | 0 | 6 | $-1,460,917 |
| Vijay Satyanand Pande | Director | June 10, 2026 A | — | 0 | 0 | $0 |
| Rekha Hemrajani | Director | June 10, 2026 A | — | 0 | 0 | $0 |
| Michael H. Davidson | Director | June 10, 2026 A | — | 0 | 0 | $0 |
| Patrick G. Enright | Director | June 10, 2026 A | — | 0 | 0 | $0 |
| Dr. James I. Healy | Director | June 10, 2026 A | — | 0 | 0 | $0 |
| Jean Pierre Garnier | Director | June 10, 2026 A | — | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
Activists & 5%+ owners 2 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| AH Bio Fund I, L.P., AH Equity Partners Bio I, L.L.C., AH Bio Fund III, L.P., AH Equity Partners Bio III, L.L.C., AH Bio Fund IV, L.P., AH Equity Partners Bio IV, L.L.C., Andreessen Horowitz LSV Fund III, L.P., AH Equity Partners LSV III, L.L.C., Marc Andreessen, Benjamin Horowitz | Oct. 4, 2024 | — | Initial filing | Passive investment | SEC |
| Sofinnova Venture Partners XI, L.P. (“SVP XI”), Sofinnova Management XI, L.P. (“SM XI LP”), Sofinnova Management XI, L.L.C. (“SM XI LLC”), Dr. James I. Healy (“Healy”), Dr. Maha Katabi (“Katabi”) | Sept. 30, 2024 | — | Initial filing | Passive investment | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF ownership Held by 36 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| PILL · Direxion Shares ETF Trust | 0.81% | 6,165 NS | April 30, 2026 | N-PORT |
| DWAS · Invesco Exchange-Traded Fund Trust … | 0.26% | 100,818 SH | Aug. 8, 2026 | Daily |
| VFMO · VANGUARD WELLINGTON FUND | 0.16% | 127,778 SH | Aug. 8, 2026 | Daily |
| IWC · iShares Trust | 0.09% | 118,766 SH | Aug. 8, 2026 | Daily |
| IHE · iShares Trust | 0.08% | 113,984 SH | Aug. 8, 2026 | Daily |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.05% | 27,617 SH | Aug. 8, 2026 | Daily |
| BIB · ProShares Trust | 0.04% | 1,604 NS | May 31, 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0.04% | 2,418 SH | Aug. 8, 2026 | Daily |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.03% | 202,410 SH | Aug. 8, 2026 | Daily |
| IBB · iShares Trust | 0.03% | 230,833 SH | Aug. 8, 2026 | Daily |
| AVSC · AMERICAN CENTURY ETF TRUST | 0.03% | 43,526 NS | May 31, 2026 | N-PORT |
| IWN · iShares Trust | 0.02% | 293,863 SH | Aug. 8, 2026 | Daily |
| GSSC · Goldman Sachs ETF Trust | 0.02% | 10,835 NS | May 31, 2026 | N-PORT |
| RSSL · Global X Funds | 0.02% | 13,075 NS | April 30, 2026 | N-PORT |
| ITWO · ProShares Trust | 0.01% | 1,420 NS | May 31, 2026 | N-PORT |
| IWM · iShares Trust | 0.01% | 897,031 SH | Aug. 8, 2026 | Daily |
| SCHA · SCHWAB STRATEGIC TRUST | 0.01% | 142,676 NS | May 31, 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.01% | 367,869 SH | Aug. 8, 2026 | Daily |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.01% | 3,710 SH | Aug. 8, 2026 | Daily |
| DFAS · Dimensional ETF Trust | 0.01% | 79,583 NS | April 30, 2026 | N-PORT |
| UWM · ProShares Trust | 0.01% | 1,111 NS | May 31, 2026 | N-PORT |
| URTY · ProShares Trust | 0.01% | 1,121 NS | May 31, 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.00% | 12,106 SH | Aug. 8, 2026 | Daily |
| ONEQ · Fidelity Commonwealth Trust | 0.00% | 20,675 NS | May 31, 2026 | N-PORT |
| IWO · iShares Trust | 0.00% | 31,584 SH | Aug. 8, 2026 | Daily |
| HDG · ProShares Trust | 0.00% | 28 NS | May 31, 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.00% | 1,850 NS | April 30, 2026 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0.00% | 16,108 NS | May 31, 2026 | N-PORT |
| ITOT · iShares Trust | 0.00% | 45,805 SH | Aug. 8, 2026 | Daily |
| IWV · iShares Trust | 0.00% | 8,951 SH | Aug. 8, 2026 | Daily |
| DFAC · Dimensional ETF Trust | 0.00% | 13,304 NS | April 30, 2026 | N-PORT |
| AVUS · AMERICAN CENTURY ETF TRUST | 0.00% | 1,959 NS | May 31, 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0.00% | 2,074 NS | April 30, 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0.00% | 893 NS | April 30, 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 1,140,593 SH | Aug. 8, 2026 | Daily |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 2,774 SH | Aug. 8, 2026 | Daily |